4//SEC Filing
DAWES KAREN A 4
Accession 0001828185-24-000058
CIK 0001828185other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 4:23 PM ET
Size
5.8 KB
Accession
0001828185-24-000058
Insider Transaction Report
Form 4
DAWES KAREN A
Director
Transactions
- Award
Share Option (Right to Buy)
2024-05-10+19,516→ 19,516 totalExercise: $2.34Exp: 2034-05-10→ Ordinary Shares (19,516 underlying)
Footnotes (2)
- [F1]The shares underlying this option shall vest in full on the earlier of (i) May 10, 2025 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
Barinthus Biotherapeutics plc.
CIK 0001828185
Entity typeother
Related Parties
1- filerCIK 0001261506
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 4:23 PM ET
- Size
- 5.8 KB